Latest Articles
Albanese govt delivers cheaper IVF and endometriosis treatments - Sky News Australia
Albanese govt delivers cheaper IVF and endometriosis treatments Sky News Australia
Published: March 16, 2025, 12:33 a.m.
Endometrial Cancer Combo Treatment Shows Promise - Mirage News
Endometrial Cancer Combo Treatment Shows Promise Mirage News
Published: March 15, 2025, 11:08 p.m.
Taylour Paige shares photos after endometriosis surgery and details symptoms: ‘The pain would make me see stars’ - AOL
Taylour Paige shares photos after endometriosis surgery and details symptoms: ‘The pain would make me see stars’ AOL
Published: March 15, 2025, 11:01 p.m.
Not just a painful period: Bridgeport woman promotes endometriosis education and awareness - News 12 Connecticut
Not just a painful period: Bridgeport woman promotes endometriosis education and awareness News 12 Connecticut
Published: March 15, 2025, 10:24 p.m.
Not just a painful period: Bridgeport woman promotes endometriosis education and awareness - News 12 Bronx
Not just a painful period: Bridgeport woman promotes endometriosis education and awareness News 12 Bronx
Published: March 15, 2025, 10:24 p.m.
Endo The Battle: National World launches endometriosis campaign - and we want to hear from you - Shropshire Star
Endo The Battle: National World launches endometriosis campaign - and we want to hear from you Shropshire Star
Published: March 15, 2025, 5:15 p.m.
Endo The Battle: National World launches endometriosis campaign - and we want to hear from you - Express & Star
Endo The Battle: National World launches endometriosis campaign - and we want to hear from you Express & Star
Published: March 15, 2025, 5:15 p.m.
Olaparib After Durvalumab/Chemo Boosts PFS in Subgroups of pMMR Endometrial Cancer - OncLive
Olaparib After Durvalumab/Chemo Boosts PFS in Subgroups of pMMR Endometrial Cancer OncLive
Published: March 15, 2025, 4:52 p.m.
Cadonilimab Plus Lenvatinib Proves Active in Platinum-Pretreated, Advanced Endometrial Cancer - OncLive
Cadonilimab Plus Lenvatinib Proves Active in Platinum-Pretreated, Advanced Endometrial Cancer OncLive
Published: March 15, 2025, 3:35 p.m.
Nivolumab Yields High Clinical CR Rates Allowing for Surgery Omission in dMMR/MSI-H Endometrial Cancer - OncLive
Nivolumab Yields High Clinical CR Rates Allowing for Surgery Omission in dMMR/MSI-H Endometrial Cancer OncLive
Published: March 15, 2025, 3:27 p.m.
Link copied to clipboard!